Merck.com - Corporate News
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
95 records returned
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - November 4, 2009 Category: Pharmaceuticals Source Type: news
New Merck Begins OperationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - November 4, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough to Complete Merger TodayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - November 3, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough Receive Approvals From U.S. Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for MergerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - October 29, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough Receive Approval From European Commission for MergerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - October 23, 2009 Category: Pharmaceuticals Source Type: news
The Supreme Court of Canada Will Not Review the Saskatchewan Court of Appeal Judgment Overturning a Class Certification Order in VIOXX® ActionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - October 22, 2009 Category: Pharmaceuticals Source Type: news
300 Doctors at your Fingertips: New Merck Manuals Deliver Convenient and Trusted Medical Information to ConsumersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - October 8, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA®, Seasonal Influenza Vaccine from CSL BiotherapiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 28, 2009 Category: Pharmaceuticals Source Type: news
Sanofi-aventis Completes Acquisition of Merck's Interest in MerialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 18, 2009 Category: Pharmaceuticals Source Type: news
Mistrial Declared in First Federal FOSAMAX® TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 11, 2009 Category: Pharmaceuticals Source Type: news
Three Directors Set For Newly-Combined MerckEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 3, 2009 Category: Pharmaceuticals Source Type: news
Merck CEO Announces Structure and Global Leadership Team for New MerckEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 31, 2009 Category: Pharmaceuticals Source Type: news
Merck Wins SINGULAIR® Patent Infringement LawsuitEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 19, 2009 Category: Pharmaceuticals Source Type: news
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District CourtEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 11, 2009 Category: Pharmaceuticals Source Type: news
Merck Shareholders Approve Merger With Schering-PloughEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 7, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 5, 2009 Category: Pharmaceuticals Source Type: news
Sanofi-aventis to Acquire Merck's Interest in MerialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 30, 2009 Category: Pharmaceuticals Source Type: news
Merck Reports Proposed Settlement of Litigation Involving Planned Merger with Schering-PloughEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 24, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 15, 2009 Category: Pharmaceuticals Source Type: news
Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed MergerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - June 22, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Statement on Medicare Part D AssistanceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - June 20, 2009 Category: Pharmaceuticals Source Type: news
Merck Statement on United States Patent & Trademark Office Decision to Reexamine the SINGULAIR® PatentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - May 29, 2009 Category: Pharmaceuticals Source Type: news
Schering-Plough and Merck Provide Update on Distribution AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - May 27, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Statement on Health Reform Meeting with President ObamaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - May 11, 2009 Category: Pharmaceuticals Source Type: news
Merck Statement on California Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for VIOXX® CostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - May 8, 2009 Category: Pharmaceuticals Source Type: news
Solar Energy Tapped to Power World Headquarters of Merck & Co., Inc.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - April 15, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. and Santen Sign Licensing Agreement In OphthalmologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - April 15, 2009 Category: Pharmaceuticals Source Type: news
Court of Appeal for Saskatchewan Allows Merck's Appeal and Overturns Class Certification of Vioxx ActionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 30, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 23, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Donates Antimalarial Candidate to Medicines for Malaria Venture for Use in Developing WorldEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 18, 2009 Category: Pharmaceuticals Source Type: news
Merck Statement on New Jersey Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Out-of-Pocket VIOXX® CostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 17, 2009 Category: Pharmaceuticals Source Type: news
Merck and schering-plough to mergeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 9, 2009 Category: Pharmaceuticals Source Type: news
Dr. Thomas Cech Nominated to Join Merck Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - February 25, 2009 Category: Pharmaceuticals Source Type: news
Carlos E. Represas Elected to Merck Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - February 17, 2009 Category: Pharmaceuticals Source Type: news
Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from InsmedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - February 12, 2009 Category: Pharmaceuticals Source Type: news
Dr. D. Gary Gilliland, Internationally-Recognized Physician and Researcher, Joins Merck Research Labs as Head of Oncology ResearchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - February 2, 2009 Category: Pharmaceuticals Source Type: news
Merck Reaffirms Cardiovascular Research CommitmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - November 8, 2008 Category: Pharmaceuticals Source Type: news
Merck Takes Important Steps to Enhance TransparencyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 25, 2008 Category: Pharmaceuticals Source Type: news
Star-Ledger Letter to the Editor from Dick PasternakEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 12, 2008 Category: Pharmaceuticals Source Type: news
Federal Court of Appeals in a Divided Decision Reverses District Court Ruling Dismissing VIOXX® Securities Class ActionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 9, 2008 Category: Pharmaceuticals Source Type: news
NYT Letter to the Editor from Peter KimEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - September 5, 2008 Category: Pharmaceuticals Source Type: news
NYT Letter to the Editor from Dick ClarkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 20, 2008 Category: Pharmaceuticals Source Type: news
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - August 18, 2008 Category: Pharmaceuticals Source Type: news
Merck to Fund U.S. VIOXX® Product Liability Resolution ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 17, 2008 Category: Pharmaceuticals Source Type: news
Leslie A. "Les" Brun Elected to Merck Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 15, 2008 Category: Pharmaceuticals Source Type: news
TREDAPTIVE™ (nicotinic acid /laropiprant) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and TriglyceridesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - July 11, 2008 Category: Pharmaceuticals Source Type: news
The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Concludes Review of ARCOXIA™ (etoricoxib)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - June 26, 2008 Category: Pharmaceuticals Source Type: news
